View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Modality Solutions
15 September 2016

Modality Solutions to Sponsor and Present at 14th Annual Cold Chain GDP & Temperature Management Logistics Global Forum

Cold chain management solutions company Modality Solutions has announced it will sponsor one of the largest events for temperature controlled life science supply chains, 14th Annual Cold Chain Management Logistics Global Forum.

Joined by 850 temperature-controlled life science leaders, the company will also be presenting an innovative approach to understanding thermal passive shipper performance, as well as hosting and presenting the second day’s pre-conference workshop ‘Using Performance Curves to Define OQ Test Profiles and Optimal Designs for Passive Shipping Containers’.

Modality Solutions’ Principal Paul Harber and Senior Engineering Advisor of Eli Lilly & Company Bernard McGarvey will examine the current approaches to selecting passive shippers and how they can fail. How to evaluate lane data and compile it into a thermal profile for use in qualification will be discussed, as well as performance curves for passive shippers, how they can be used, and the methodologies of development. Participants will take away tools and a methodology for defining shipper capabilities with a performance curve and knowledge of how to quantify the risk of failure within specified lanes.

In its fourteenth installment, the Cold Chain Global Forum has significantly expanded its topic focuses, session formats, speaking faculty, and vendor options to help meet the industry’s emerging and ongoing challenges for 2016. The event is designed to include eight pre-conference workshops, two in-depth master classes, two days of main conference sessions, roundtable discussions, and panel discussions, as well as more than 14 hours of networking to discuss the most important challenges, effective strategies, and solutions within the cold chain industry.

Modality Solutions’ president Gary Hutchinson said: "We encourage attendees to stop by our conference booth 423 to ask questions about their cold chain thermal packaging, transport validation, and logistics challenges.

"We are committed to helping life science companies explore cost-reduction strategies, understand changing industry standards, and initiate risk management processes to ensure compliance, quality and product integrity.

"IQPC’s divisional director of cold chain portfolio Claudia Rubino said: "We’re thrilled to head back to Boston once again for the Cold Chain Global Forum.

"The Global Forum continues to be the leading event for temperature-controlled life science supply chains, and we’re pleased to have Modality Solutions partner with us to help make the event a success."

Modality Solutions will be present from 26 September to 30 September at the Hynes Veterans Memorial Convention Center in Boston, Massachusetts.

Competing priorities, changing expectations, cost pressures, sustainability initiatives, emerging markets - these are some of the challenges facing cold chain management professionals every day. Solutions...
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell...
Immunomedics (www.immunomedics.com) is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer.
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York City that specialises in discovering, developing and delivering innovative medicines for patients with...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology